How have CALA shares performed in 2024?

Calithera Biosciences' stock was trading at $0.03 at the beginning of the year. Since then, CALA shares have decreased by 16.5% and is now trading at $0.0251. View the best growth stocks for 2024 here .

How were Calithera Biosciences' earnings last quarter?

Calithera Biosciences, Inc. (NASDAQ:CALA) announced its quarterly earnings data on Monday, November, 8th. The biotechnology company reported ($3.00) earnings per share for the quarter, beating analysts' consensus estimates of ($4.60) by $1.60. The biotechnology company had revenue of $6.75 million for the quarter. During the same quarter in the previous year, the business posted ($6.40) EPS.

When did Calithera Biosciences' stock split?

Calithera Biosciences's stock reverse split before market open on Wednesday, June 15th 2022. The 1-20 reverse split was announced on Wednesday, June 15th 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Calithera Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Calithera Biosciences investors own include Puma Biotechnology (PBYI) , Incyte (INCY) , BioMarin Pharmaceutical (BMRN) , (MDVN) (MDVN) , Celadon Group (CGI) , Dynavax Technologies (DVAX) , Rigel Pharmaceuticals (RIGL) , First Solar (FSLR) , Plug Power (PLUG) and Sorrento Therapeutics (SRNE) .

How do I buy shares of Calithera Biosciences?

Shares of CALA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:CALA

Calithera Biosciences (CALA) Stock Price, News & Analysis

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Free CALA Stock Alerts

$0.03

-0.01 (-28.53%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.03
▼
$0.03
50-Day Range: $0.02
▼
$0.05
52-Week Range: $0.01
▼
$0.50

Volume: 1,075 shs
Average Volume: 857 shs
Market Capitalization: $121,993.50

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials Insider Trades SEC Filings Social Media Sustainability

Get Calithera Biosciences alerts:

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

About Calithera Biosciences Stock (NASDAQ:CALA)

Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.

CALA Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CALA Stock News Headlines

April 14, 2024 | americanbankingnews.com

Calithera Biosciences (NASDAQ:CALA) Coverage Initiated by Analysts at StockNews.com

February 24, 2024 | uk.investing.com

Arcus Biosciences Inc (RCUS)

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

August 12, 2023 | npr.org

Christina Cala

June 29, 2023 | seekingalpha.com

Calithera Biosciences cancels special meeting due to lack of quorum

June 1, 2023 | finance.yahoo.com

CALA - Calithera Biosciences, Inc.

May 20, 2023 | finanznachrichten.de

Calithera Biosciences, Inc.: Calithera Biosciences Announces Update on Complete Liquidation and Dissolution

May 19, 2023 | travel.usnews.com

Cala Mariolu

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

May 19, 2023 | seekingalpha.com

Calithera Biosciences plans special meeting to seek approval for liquidation and dissolution plan

May 19, 2023 | finance.yahoo.com

Calithera Biosciences Announces Update on Complete Liquidation and Dissolution

May 13, 2023 | travel.usnews.com

Cala Llombards

May 12, 2023 | investing.com

Calithera Biosciences Inc (CALA) Earnings Dates & Reports

January 11, 2023 | marketwatch.com

Calithera Biosciences Shares Plummet on Liquidation Plans >CALA

January 11, 2023 | marketwatch.com

Calithera Biosciences to Liquidate >CALA

January 10, 2023 | finance.yahoo.com

Biotech company Calithera plans its own death. Will others follow?

January 9, 2023 | finanznachrichten.de

Calithera Biosciences, Inc.: Calithera Biosciences Announces Board Approval of Complete Liquidation and Dissolution

January 9, 2023 | markets.businessinsider.com

Calithera Biosciences Board Of Directors Determine Dissolution Of Company

January 9, 2023 | finance.yahoo.com

Calithera Biosciences Stock Nosedives On Complete Liquidation, Dissolution

January 9, 2023 | finance.yahoo.com

Calithera Biosciences Announces Board Approval of Complete Liquidation and Dissolution

November 15, 2022 | finanznachrichten.de

Calithera Biosciences, Inc.: Calithera Biosciences Reports Third Quarter 2022 Financial Results and Business Update

November 15, 2022 | seekingalpha.com

Calithera Biosciences, Inc. (CALA) Q3 2022 Earnings Call Transcript

November 15, 2022 | finance.yahoo.com

Calithera Biosciences Reports Third Quarter 2022 Financial Results and Business Update

November 8, 2022 | finance.yahoo.com

Calithera Biosciences to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022

October 3, 2022 | marketwatch.com

Calithera Biosciences Gets FDA Fast Track For Lung Cancer Drug

October 3, 2022 | nasdaq.com

Calithera Gets FDA Fast Track Designation For Sapanisertib For Squamous Lung Cancer Treatment

October 3, 2022 | finance.yahoo.com

Calithera's stock is up 14% after announcing Fast Track designation for lung-cancer drug candidate

See More Headlines

Receive CALA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Calithera Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/08/2021
Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: NASDAQ:CALA
CUSIP: N/A
CIK: 1496671
Web: www.calithera.com
Phone: (650) 870-1000
Fax: N/A
Employees: 8
Year Founded: 2010

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $9.75 million
Price / Sales: 0.01
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.40) per share
Price / Book: -0.06

Miscellaneous

Outstanding Shares: 4,870,000
Free Float: 4,550,000
Market Cap: $121,993.50
Optionable: Not Optionable
Beta: -0.17

Social Links

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

Ms. Stephanie Wong (Age 50)
CFO & Secretary
Comp: $752.42k
Dr. Christopher J. Molineaux Ph.D. (Age 71)
Senior Vice President of Development
Comp: $405k
Mr. Frank Parlati Ph.D. (Age 55)
Senior Vice President of Research

Key Competitors

View All Competitors

CALA Stock Analysis - Frequently Asked Questions

How have CALA shares performed in 2024?: Calithera Biosciences' stock was trading at $0.03 at the beginning of the year. Since then, CALA shares have decreased by 16.5% and is now trading at $0.0251.
View the best growth stocks for 2024 here.
How were Calithera Biosciences' earnings last quarter?: Calithera Biosciences, Inc. (NASDAQ:CALA) announced its quarterly earnings data on Monday, November, 8th. The biotechnology company reported ($3.00) earnings per share for the quarter, beating analysts' consensus estimates of ($4.60) by $1.60. The biotechnology company had revenue of $6.75 million for the quarter. During the same quarter in the previous year, the business posted ($6.40) EPS.
When did Calithera Biosciences' stock split?: Calithera Biosciences's stock reverse split before market open on Wednesday, June 15th 2022. The 1-20 reverse split was announced on Wednesday, June 15th 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Calithera Biosciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Calithera Biosciences investors own include Puma Biotechnology (PBYI), Incyte (INCY), BioMarin Pharmaceutical (BMRN), (MDVN) (MDVN), Celadon Group (CGI), Dynavax Technologies (DVAX), Rigel Pharmaceuticals (RIGL), First Solar (FSLR), Plug Power (PLUG) and Sorrento Therapeutics (SRNE).
How do I buy shares of Calithera Biosciences?: Shares of CALA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CALA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Calithera Biosciences (CALA) Stock Price, News & Analysis

About Calithera Biosciences Stock (NASDAQ:CALA)

CALA Stock Price History

CALA Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

CALA Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info